LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Lantheus
LNTH
eBay
EBAY
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Constellation Brands
STZ
US Stock MarketDetailed Quotes
ELTX Elicio Therapeutics
- 7.840
- -0.470-5.66%
Close Mar 3 16:00 ET
94.50MMarket Cap-1.80P/E (TTM)
8.640High7.686Low31.46KVolume8.400Open8.310Pre Close249.72KTurnover0.35%Turnover RatioLossP/E (Static)12.05MShares11.45052wk High-4.98P/B70.89MFloat Cap3.34252wk Low--Dividend TTM9.04MShs Float263.000Historical High--Div YieldTTM11.48%Amplitude2.960Historical Low7.936Avg Price1Lot Size
About Elicio Therapeutics Company
Elicio Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of cancer immunotherapies. It focuses on its Amphiphile platform for trafficking lymph nodes. The company was founded by Darrell Irvine in August 2011 and is headquartered in Boston, MA.
Company Profile
SymbolELTX
Company NameElicio Therapeutics
Listing DateFeb 5, 2021
Founded2011
CEOMr. Robert Connelly
MarketNASDAQ
Employees32
Fiscal Year Ends12-31
Address451 D Street,5th floor, Suite 501
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-857-209-0050
Websitehttp://www.elicio.com
Company Executives
- Name
- Position
- Salary
- Robert Connelly
- Chief Executive Officer, President, Director, Principal Accounting Officer and Principal Financial Officer
- 678.30K
- Dr. Christopher Haqq, M.D.,PhD
- Executive Vice President, Head of Research and Development and Chief Medical Officer
- 673.82K
- Dr. Peter DeMuth, PhD
- Chief Scientific Officer
- --
- Dr. Julian Ada PhD
- Chairman of the Board
- 96.05K
- Dr. Jay R. Venkatesan, M.D.
- Director
- 45.76K
- Yekaterina Chudnovsky
- Director
- 48.68K
- Dr. Robert R. Ruffolo, Jr, Ph.D
- Independent Director
- 63.26K
- Karen J. Wilson
- Independent Director
- 101.02K
- Dr. Allen R. Nissenson,M.D.
- Independent Director
- 91.22K
- Carol Gail Ashe
- Independent Director
- 71.59K